Company / Operating Cash Flow
Doximity Operating Cash Flow History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$273.3M
FY2024
5-year range
$126.6M / $273.3M
FY2020-FY2024
Trend
+48.4%
vs FY2023
Sector context
#73 of 158
Health Care
What the data says
At $273M, Doximity's operating cash flow ranks #73 of 158 in the Health Care sector. Operating Cash Flow has increased for 5 consecutive years, from $26M in FY2019 to $273M in FY2024.
Based on SEC 10-K filings.
$273M in FY2024 with a 5-year CAGR of +59.8%.
Improved from $180M to $273M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +29.2%
- 5-Year CAGR
- +59.8%
- 10-Year CAGR
- -
Sector benchmark
#73 of 158 in Health CareTop 46% of 158This company $273.3M Sector average $1.0B
▼
-73.5% below sector average
Key checks
Key Insights
- Doximity's operating cash flow has grown for 5 consecutive years.
- 5-year CAGR of +59.8%, indicating consistent growth.
- In FY2024, operating cash flow increased 48.4% year-over-year.
- Ranks #73 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $273.3M | +48.4% |
| FY2023 | $184.1M | +2.5% |
| FY2022 | $179.6M | +41.9% |
| FY2021 | $126.6M | +52.5% |
| FY2020 | $83.0M | +216.7% |
| FY2019 | $26.2M | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026